March 26, 2019
Rose
The agreement that stemmed from patients who used the popular blood thinner Xarelto caps one of the more high-profile instances of product liability litigation facing the pharmaceutical industry in recent years.
from Kaiser Health News https://ift.tt/2TZAOyA
March 26, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
To Tame Prescription Prices, HHS Dips A Toe Into Drug Importation Stream- Podcast: KHN’s ‘What The Health?’ Let’s Talk Politics
- Patients With Chronic Pain Feel Caught In An Opioid-Prescribing Debate
- Viewpoints: Keeping Guns Away From Dangerous People Is About To Get Much Tougher; Time To Level Playing Field For Medicare
- State Highlights: Washington Governor Vows To Forgo Title X Funding If New Rule Goes Into Effect; Quality Of Care For Connecticut Inmates Criticized At Hearing
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment